Syantra
Calgary, CA · 3 known investors
Syantra develops the patent-pending Onco-ID platform for early cancer detection, using a biomarker and drug target discovery technology to support oncologists and pharmaceutical scientists in creating personalized, precision cancer treatments. Founded from research at the University of Calgary, it serves the oncology diagnostics and precision medicine market.
Founders & leadership
DT
Dr. Tina RinkerCo-founder
TR

Tina RinkerCo-founder
KF

Ken FuhCo-founder
RM

Randy MooreCo-founder
BS

Bob ShepherdCo-founder
Investors · 3
Competitors · 3
by search overlapNatera7 shared keywordsNatera develops genetic tests and diagnostics using cell-free DNA technology to detect diseases including cancers, genetic disorders, and transplant-related conditions. The company serves patients, physicians, and healthcare systems across oncology, women's health, and organ health.
Outcomes4Me5 shared keywordsOutcomes4Me is an AI-driven patient platform that integrates with NCCN clinical oncology guidelines to provide personalized cancer care guidance, treatment options, clinical trial recommendations, and genetic testing information. The platform serves cancer patients directly by offering decision support tools and health data management to improve treatment access and outcomes.
Labcorp5 shared keywordsLabcorp provides clinical laboratory testing, diagnostics, and lab data services for patients, healthcare providers, and biopharma companies, including genetic health panels, oncology testing, and self-ordered lab tests. It also offers AI-powered tools such as a results-explaining consumer app, a diagnostic assistant integrated into EHRs, and a laboratory data analytics platform to support drug development and clinical research.
Companies competing with Syantra for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Syantra do?
- Syantra develops the patent-pending Onco-ID platform for early cancer detection, using a biomarker and drug target discovery technology to support oncologists and pharmaceutical scientists in creating personalized, precision cancer treatments. Founded from research at the University of Calgary, it serves the oncology diagnostics and precision medicine market.
- Who founded Syantra?
- Syantra was founded by Dr. Tina Rinker, Tina Rinker, Ken Fuh, Randy Moore, Bob Shepherd.
- Who are Syantra's investors?
- Syantra's investors include The 51 Ventures, Thin Air Labs, UCeed Funds.
- Where is Syantra headquartered?
- Syantra is headquartered in Calgary, CA.

